DIARY-Europe's STOXX 600 corporate earnings week ahead Aug 30 (Reuters) - Diary of Europe's STOXX 600 (.STOXX) corporate earnings for the week ahead EUROPE'S STOXX 600 EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 02-Sep-2024 09:00 BAYGn.DE Bayer AG Bayer AG Investor Webinar to Discuss Results from FINEARTS-HFP 02-Sep-2024 09:00 PZU.WA Powszechny Zaklad Ubezpieczen SA Half Year 2024 Powszechny Zaklad Ubezpieczen SA Investor Chat (Polish) 03-Sep-2024 NTS BKWB.S BKW AG Half Year

DIARY-Germany corporate earnings week ahead Aug 30 (Reuters) - Diary of Germany (.GDAXI) corporate earnings for the week ahead GERMANY EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 02-Sep-2024 09:00 BAYGn.DE Bayer AG Bayer AG Investor Webinar to Discuss Results from FINEARTS-HFP ** All times are listed in AMC - 'After market close', or BMO - 'Before market opens', or DBH - 'During business hours', or NTS - 'No time scheduled' ** This Diary does not provide the EPS estimate fig

FACTBOX-European companies cut jobs as economy sputters Adds Shell Aug 30 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * PKP CARGO PKPP.WA : Poland's largest freight co

BRIEF-Bayer Starts Late Stage Trial In Lung Cancer Therapy Aug 29 (Reuters) - Bayer AG BAYGn.DE : STARTS PHASE III TRIAL IN NON-SMALL CELL LUNG CANCER (NSCLC) FIRST PATIENT ENROLLED IN PHASE III SOHO-02 TRIAL OF INVESTIGATIONAL AGENT BAY 2927088 IN TREATMENT-NAÏVE PATIENTS WITH ADVANCED NSCLC WITH HER2-ACTIVATING MUTATIONS DATA FROM PHASE I/II SOH

UPDATE 1-ADNOC finalising due diligence on Covestro, sources say Adds details, background in paragraphs 4-8 By Emma-Victoria Farr FRANKFURT, Aug 28 (Reuters) - Abu Dhabi National Oil Company (ADNOC) is finalising due diligence for a takeover of Covestro 1COV.DE in a deal that could reach 11.7 billion euros ($13 billion), two sources familiar with the matter told Reuters on Wednesday.

BRIEF-Bayer Says Co And NextRNA Therapeutics Enter Strategic Collaboration To Develop Small Molecules Targeting Long Non-Coding RNAs In Oncology Aug 28 (Reuters) - Bayer AG BAYGn.DE : BAYER AND NEXTRNA THERAPEUTICS ENTER STRATEGIC COLLABORATION TO DEVELOP SMALL MOLECULES TARGETING LONG NON-CODING RNAS (LNCRNAS) IN ONCOLOGY BAYER AG: NEXTRNA WILL RE

BRIEF-Bayer To Collaborate With NextRNA In Oncology Treatment Aug 28 (Reuters) - Bayer AG BAYGn.DE : ENTERS COLLABORATION WITH NEXTRNA TO DEVELOP SMALL MOLECULES TARGETING LONG NON-CODING RNAS IN ONCOLOGY NEXTRNA WILL RECEIVE UP TO $547 MILLION FOR TWO ONCOLOGY PROGRAMS Further company coverage: [BAYGn.DE] (Gdansk Newsroom)

UPDATE 3-US says Bioceres genetically modified wheat safe to grow Updates Aug 27 story, adds comments from Bioceres in paragraphs 2-3 and 11; from Japan in paragraphs 13-14; and a German grain trader in paragraph 16 By Tom Polansek and Julie Ingwersen CHICAGO, Aug 28 (Reuters) - A type of genetically modified wheat developed by Argentina's Bioceres Crop Solutions BIOX.O may be safely grown in the United States, the U.S.

FACTBOX-European companies cut jobs as economy sputters Adds Tamedia, UPM Aug 27 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * PKP CARGO PKPP.WA : Poland's largest fre

BRIEF-Bayer: Will Present Phase III Data On Finerenone Aug 26 (Reuters) - Bayer AG BAYGn.DE : ADVANCING IN STUDIES ON HEART FAILURE MANAGEMENT SHOWCASING LATE-BREAKING HEART FAILURE DATA FROM PHASE III STUDY FINEARTS-HF WITH FINERENONE WILL PRESENT LATE-BREAKING PHASE III DATA ON FINERENONE (KERENDIA™) IN PATIENTS WITH HEART FAILURE (HF) AND A LE

BRIEF-Bayer Reports JAMAs Phase III Data On Elinzanetant Aug 22 (Reuters) - BAYER AG BAYGn.DE : JOURNAL OF AMERICAN MEDICAL ASSOCIATION (JAMA) PUBLISHES ELINZANETANT PHASE III DATA OASIS 1 AND 2 STUDIES DEMONSTRATED POSITIVE RESULTS FOR INVESTIGATIONAL COMPOUND ELINZANETANT WHICH MET ALL PRIMARY ENDPOINTS Further company coverage: [BAYGn.DE] (Gdans

UPDATE 3-Deutsche Bank settles bulk of Postbank claims, but others hold out Updates with graphic By Tom Sims and Alexander Hübner FRANKFURT, Aug 22 (Reuters) - Deutsche Bank DBKGn.DE has more work to do to overcome its Postbank troubles even after announcing settlements with more than half the plaintiffs who had accused it of underpaying them in its takeover of the German retail bank in 2010. Deutsche Bank's shares initially rose about 3% on Thursday after the bank's announcement that it had re

BRIEF-Bayer Initiates Phase II Study Of Soluble Guanylate Cyclase Activator Aug 22 (Reuters) - BAYER AG BAYGn.DE : INITIATES PHASE II STUDY OF SOLUBLE GUANYLATE CYCLASE ACTIVATOR IN PATIENTS WITH CHRONIC KIDNEY DISEASE RESULTS OF THIS STUDY HAVE POTENTIAL TO PROVIDE EVIDENCE OF SGC ACTIVATOR AS A VIABLE TREATMENT OPTION FOR CARDIOVASCULAR DISEASES

UPDATE 4-Bayer wins US legal victory against Roundup cancer claims; shares surge Adds discussion of potential Supreme Court appeals in paragraphs 11-12 By Jonathan Stempel Aug 16 (Reuters) - Bayer BAYGn.DE won a legal victory in its fight to limit liability from claims its Roundup weed killer causes cancer, as a U.S. appeals court said on Thursday that federal law shields the German company from a lawsuit by a Pennsylvania landscaper.

BUZZ-Bayer tracks best day in 15 yrs after a victory in Roundup legal battle Adds background, updates share move and milestone, adds analyst comment ** Shares in Bayer BAYGn.DE e xtend morning gains and rise about 11 %, f ollowing its legal victory in the Roundup case, which might help it bring the litigation in front of the U.S. Supreme Court ** A U.S.

LIVE MARKETS-Gilts and the pound could drop further STOXX 600 up 0.5% Bayer surges on court ruling Wall St futures higher Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com GILTS AND THE POUND COULD DROP FURTHER Analysts at Capital Economics expect the Bank of England to cut interest rates by more than the market expects, which should prompt weakness in the pound GBP=D3 and gilts th

UPDATE 2-Europe's STOXX 600 clocks best week in 3 months on rate optimism For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Bayer jumps on legal victory against Roundup cancer claims UBS to liquidate $2 bln real estate fund, shares up STOXX 600 up 0.3% Updated at 1550 GMT By Pranav Kashyap and Shubham Batra Aug 16 (Reuters) - European shares ended the week with healthy gains as upbeat risk sentiment prevailed globally following a slew of U

LIVE MARKETS-STOXX set for biggest weekly gain in three months STOXX 600 up 0.4% Bayer surges on court ruling Wall St futures higher Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com STOXX SET FOR BIGGEST WEEKLY GAIN IN THREE MONTHS The STOXX 600 .STOXX is rising 0.4%, on track for a weekly gain of 2.5% if it keeps up gains throughout the day.

BUZZ-Bayer up on victory in legal battle against Roundup cancer claims ** Shares in Bayer BAYGn.DE jump 8% after it won a legal victory in its fight to limit liability from claims that its Roundup weed killer causes cancer ** A U.S. appeals court said on Thursday that federal law shields Bayer from a lawsuit by a Pennsylvania landscaper, which claimed it had failed to provide a cancer warning on the label of Roundup ** The U.S.

EXCLUSIVE-Deutsche Bank's proposed Postbank case settlement offer rejected by plaintiffs Updates with plaintiff lawyer statement, context By Tom Sims FRANKFURT, Aug 16 (Reuters) - Deutsche Bank DBKGn.DE has proposed a settlement to shareholders who sued Germany's largest bank for underpaying them for the acquisition of Postbank but the offer is too low, a lawyer for the plaintiffs said on Friday.